Taho Pharmaceuticals Ltd. (TPEX:6467)

Taho Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	101.52	245.87	151.71	74.3	83.99	224.22
Short-Term Investments	300	250	78.07	32	44.64	-
Cash & Short-Term Investments	401.52	495.87	229.77	106.3	128.63	224.22
Cash Growth	83.34%	115.81%	116.16%	-17.36%	-42.63%	-31.75%
Accounts Receivable	-	-	-	-	1.38	9.74
Other Receivables	0.78	0.87	0.29	0.03	0.13	0.12
Receivables	0.78	0.87	0.29	0.03	1.51	9.86
Inventory	-	-	-	-	3.95	8.47
Prepaid Expenses	2.45	2.18	3.24	4.96	8.94	7.9
Other Current Assets	-	-	-	-	1.35	0.13
Total Current Assets	404.74	498.92	233.31	111.29	144.38	250.58
Property, Plant & Equipment	25.6	24.86	23.55	4.33	30.26	47.37
Long-Term Investments	7.33	8.01	-	-	-	-
Other Intangible Assets	0.85	-	-	-	17.32	21.73
Other Long-Term Assets	27.25	28.91	26.34	22.93	7.48	6.09
Total Assets	465.77	560.7	283.2	138.54	199.44	325.77
Accounts Payable	-	-	-	-	12.03	1.09
Accrued Expenses	3.57	24.74	21.53	10.5	3.93	0.21
Short-Term Debt	-	-	-	-	0.91	0.51
Current Portion of Leases	5.44	5.34	4.97	-	-	-
Current Unearned Revenue	-	0.71	-	0.19	-	-
Other Current Liabilities	2.31	2.28	33.2	35.8	8.47	10.4
Total Current Liabilities	11.32	33.06	59.7	46.49	25.35	12.21
Long-Term Leases	8.57	11.31	16.65	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	-	0.64	1.01
Other Long-Term Liabilities	0.11	0.12	0.15	-	-	0.02
Total Liabilities	19.99	44.5	76.5	46.49	25.99	13.24
Common Stock	514.28	512.16	423.07	372.97	523.12	523.12
Additional Paid-In Capital	4.08	388.42	256.19	70.96	1.88	303.89
Retained Earnings	-71.9	-384.38	-472.57	-351.89	-354.68	-519.4
Comprehensive Income & Other	-0.69	-	-	-	3.13	4.92
Shareholders' Equity	445.78	516.2	206.69	92.05	173.45	312.53
Total Liabilities & Equity	465.77	560.7	283.2	138.54	199.44	325.77
Total Debt	14.01	16.65	21.62	-	0.91	0.51
Net Cash (Debt)	387.51	479.22	208.15	106.3	127.72	223.71
Net Cash Growth	93.90%	130.22%	95.82%	-16.77%	-42.91%	-31.90%
Net Cash Per Share	7.86	10.56	5.37	2.96	2.44	4.28
Filing Date Shares Outstanding	51.43	51.22	51.22	35.96	52.31	52.31
Total Common Shares Outstanding	51.43	51.22	51.22	35.96	52.31	52.31
Working Capital	393.42	465.86	173.61	64.79	119.03	238.37
Book Value Per Share	8.67	10.08	4.04	2.56	3.32	5.97
Tangible Book Value	444.93	516.2	206.69	92.05	156.13	290.8
Tangible Book Value Per Share	8.65	10.08	4.04	2.56	2.98	5.56
Machinery	61.24	59.45	52.84	54.42	53.06	53.61
Leasehold Improvements	17.25	14.03	13.81	13.75	10.72	19.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.